ondansetron "bluefish" 8 mg smeltetabletter
bluefish pharmaceuticals ab - ondansetron - smeltetabletter - 8 mg
memantine mylan
mylan pharmaceuticals limited - memantinhydrochlorid - alzheimers sygdom - other anti-dementia drugs, psychoanaleptics, - behandling af patienter med moderat til svær alzheimers sygdom.
takhzyro
takeda pharmaceuticals international ag ireland branch - lanadelumab - angioødemer, arvelige - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler til systemisk brug, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
ondansetron "bluefish" 8 mg filmovertrukne tabletter
bluefish pharmaceuticals ab - ondansetronhydrochloriddihydrat - filmovertrukne tabletter - 8 mg
krystexxa
crealta pharmaceuticals ireland limited - pegloticase - gigt - antigout præparater - krystexxa er indiceret til behandling af svær invaliderende kroniske tophaceous gigt i voksne patienter der kan have erosive fælles engagement og der har ikke kunnet normalisere serum urinsyre med xanthin oxidase hæmmere på maksimalt lægeligt passende dosis eller for hvem disse lægemidler er kontraindiceret.
omeprazol "bluefish" 10 mg enterotabletter
bluefish pharmaceuticals ab - omeprazol - enterotabletter - 10 mg
omeprazol "bluefish" 20 mg enterotabletter
bluefish pharmaceuticals ab - omeprazol - enterotabletter - 20 mg
ozalin 2 mg/ml oral opløsning, enkeltdosisbeholder
primex pharmaceuticals oy - midazolam - oral opløsning, enkeltdosisbeholder - 2 mg/ml
clopidogrel / acetylsalicylic acid mylan
mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antitrombotiske midler - clopidogrel/acetylsalicylsyre mylan er angivet for den sekundære forebyggelse af atherothrombotic hændelser hos voksne patienter, som allerede tager både clopidogrel og acetylsalicylsyre (asa). clopidogrel/acetylsalicylsyre mylan er en fast dosis kombination lægemiddel til fortsættelse af terapi i:non-st-segment elevation akut koronar syndrom (ustabil angina pectoris eller non-q-tak myokardieinfarkt), herunder patienter, der gennemgår en stent placering efter perkutan koronar interventionst segment elevation akut myokardieinfarkt i medicinsk behandlede patienter, der er berettiget til trombolytisk terapi.